Assistant Professor of Oncology, Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA
Institute of Cancer Therapeutics University of Bradford, UK.
Associate Professor,Faculty of Pharmacy,Department Of Pharmacology and Therapeutics,Kuwait University.
Harvard Medical School Chief, Division of Translational Therapeutics, Department of Medicine, Director of Translational Therapeutics, Cancer Research Institute, United States.
Formulation Scientist at Insys Therapeutics
Senior Research Associate, Department of Therapeutic Endocrinology, Endocrinology Research Center, Moscow, Russia
Senior Scientist/Pre-Clinical Manager, Repros Therapeutics, The Woodlands, TX
Diagnostic and Therapeutic Technologies Department, School of Health Sciences - Polytechnic Institute of Bragança, Portugal
Ph.D. in Pharmaceutical Sciences, Formulation Scientist, Insys Therapeutics, University of Nebraska Medical Center, USA
Department of Clinical and Experimental Therapeutics, University of Georgia, Augusta, USA
Postdoctoral research Fellow in the Department of Neurology and Neurotherapeutics at University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Assistant Professor in the Department of Molecular Pharmacology and Therapeutics of Loyola University Chicago, USA.
Author(s): Abdullayeva Nabat- Sumgait State University
Author(s): Michele Cicala
Author(s): Rizwana Popatia
Author(s): Yi-Kai Hong, Guey-Yueh Shi and Hua-Lin Wu
Author(s): Sara S. Abou Zekry, Ahmed Abdellatif and Hassan M. E. Azzazy
Author(s): Shaik Mahaboob Vali1, Sandeep kumar Vishwakarma1, Avinash Bardia1, Santosh K Tiwari1, G. Srinivas2, Avinash Raj2, Chaturvedula Tripura2, Pratibha Nallari3, Md. Aejaz Habeeb1, Gopal Pande2 and Aleem A Khan1*